, Tracking Stock Market Picks
Enter Symbol:
AcelRx Pharmaceuticals Inc (ACRX) [hlAlert]

up 1.89 %

AcelRx Pharmaceuticals Inc (ACRX) rated Buy with price target $8 by Canaccord Genuity

Posted on: Wednesday,  Oct 10, 2012  9:25 AM ET by Canaccord Genuity

Canaccord Genuity rated Buy AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) on 10/10/2012. Previously Canaccord Genuity rated Buy AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) on
05/26/2011., when the stock price was $4.23. Since then, AcelRx Pharmaceuticals Inc has gained 1.89% as of 01/06/2016's recent price of $4.31.
If you would have followed the previous Canaccord Genuity's recommendation on ACRX, you would have gained 1.89% of your investment in 1686 days.

AcelRx Pharmaceuticals, Inc. is a development-stage company. The Company is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. It has completed Phase 2 clinical development for two additional product candidates, the Sufentanil NanoTab BTP Management System, or ARX-02, for the treatment of cancer breakthrough pain (BTP), and the Sufentanil/Triazolam NanoTab, or ARX-03, designed to provide mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician?s office. The Company is preparing to initiate two Phase 3 clinical trials for its product candidate, the Sufentanil NanoTab PCA System, or ARX-01. ARX-02 is a product candidate for the treatment of cancer patients who suffer from breakthrough pain. ARX-03 Sufentanil/Triazolam NanoTab is a single, fixed-dose sublingual product candidate.

Canaccord Genuity’s global team of over 100 research professionals are inquisitive, experienced and committed to generating actionable investment ideas. We analyze over 725 companies in a broad range of market sectors, identifying value and defining risk for our clients.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/10/2012 9:25 AM Buy
3.09 8.00
as of 12/31/2012
1 Week up  9.79 %
1 Month   
3 Months up  33.54 %
1 YTD up  121.87 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/26/2011 11:25 AM Buy
4.23 6.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy